Non-CETP Novel Targets and New Drug Therapies Targeting HDL

Curriculum:
N/A
Credits:
1 ACPE 1 ANCC Contract Hours 1 CDR 1 AMA PRA Category 1 Credit(s)™
Launch Date:
18-Dec-12
Expiration Date:
The accreditation for this activity has expired.

Primary Audience:

No primary audience was provided.

Relevant Terms:

No primary audience was provided.

Michael H. Davidson, MD, FNLA *

Michael H. Davidson, MD, FNLA *
Clinical Professor
Director of Preventive Cardiology
The University of Chicago Pritzker School of Medicine
Chicago, IL

Michael H. Davidson, MD, is Professor of Medicine and Director of Preventive Cardiology at the University of Chicago.  He also serves as Chief Medical Officer for Omthera. Pharmaceuticals.  Dr. Davidson earned his medical degree from The Ohio State University College of Medicine in Columbus.  He then completed his residency and fellowship in cardiology at Rush University Medical Center in Chicago.
 
An active researcher, Dr. Davidson's clinical research background encompasses both pharmaceutical and nutritional clinical trials.  His extensive research on statins, novel lipid-lowering drugs, and nonpharmacologic risk factor reduction has established him as a key opinion leader in this area.  A prolific author and lecturer on lipid disorders, nutrition, and atherosclerosis, Dr. Davidson has coordinated more than 1,000 clinical trials in areas of preventive cardiology and published more than 250 articles for leading medical journals and has written 3 books on Lipidology.
 
Dr. Davidson is board-certified in internal medicine, cardiology, and clinical lipidology.  He is a Fellow of the American College of Cardiology and the American College of Chest Physicians.  In addition, he was President (2010-2011) of the National Lipid Association.  He was named in The Best Doctors in America for the past 10 years and was named Father of the Year by the American Diabetes Association, 2010.

Danielle Duffy, MD

Danielle Duffy, MD
Assistant Professor of Medicine
Division of Cardiology
Jefferson Medical College and Thomas Jefferson University
Philadelphia, PA

Dr. Duffy is an Assistant Professor of Medicine in the Division of Cardiology at the Jefferson Medical College of Thomas Jefferson University.  She serves as the Director of Cardiovascular Risk Reduction at the Jefferson Heart Institute, and is a clinical cardiologist with a focus on complex lipid management and women's cardiovascular health and prevention. She is a member of the Board of Directors of the Northeast Lipid Association as well as the Southeastern Pennsylvania Chapter of the American Heart Association. Dr. Duffy completed her undergraduate studies at Swarthmore College. She graduated from the University of Pennsylvania School of Medicine and completed her internship and residency at the Hospital of the University of Pennsylvania.  She did additional training in clinical lipidology and lipid research through an NIH sponsored training grant at the University of Pennsylvania prior to completing her fellowship in cardiovascular diseases at Thomas Jefferson University Hospital. Dr. Duffy is involved in multiple investigator-initiated and site-based clinical trials in the area of cardiovascular prevention.
1. Discuss emerging HDL- based therapeutics; their promise and potential pitfalls
2. Identify novel HDL therapies in development and analyze their role in reversing atherosclerosis
3. For Registered Nurses and Nurse Practitioners Only: Provide appropriate care and counsel for patients and their families